Latest filing published 21 Dec 2010 for Catalyst Pharmaceuticals, INC., €1,442.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -6.9%Entry US$1.16 · Close at T+365 US$1.08
- -68.8%Entry US$2.40 · Close at T+365 US$0.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jack Weinstein: trading record in brief
All filings by Jack Weinstein on record concern Catalyst Pharmaceuticals, Inc. In total, 12 filings cover trades dated from 14 August 2007 to 20 December 2010.
Every open-market trade on record is a purchase: 11 purchases worth €21k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. Since January 2010: 2 purchases and no sales on the market.
Half of the purchases are above €891 and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +6.0%. These figures describe past trades and do not predict future prices.
The latest filing, published on 21 December 2010, reports an open-market purchase of €1,442 in Catalyst Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jack Weinstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$0.9489Common Stock, par value $0.001 per shareSEC:0001161697-10-001176:0Canonical exit: 20 Mar 2011 (T+90)
- 500 shares@ US$0.96Common Stock, par value $0.001 per shareSEC:0001161697-10-001176:1Canonical exit: 20 Mar 2011 (T+90)
- 1,400 shares@ US$1.55Common Stock, par value $0.001 per shareSEC:0001161697-09-000247:0Canonical exit: 4 Jun 2009 (T+90)
- 100 shares@ US$2.24Common Stock, par value $0.001 per shareSEC:0001161697-08-001353:0Canonical exit: 18 Mar 2009 (T+90)
- 100 shares@ US$3.03Common Stock, par value $0.001 per shareSEC:0001161697-08-001172:0Canonical exit: 31 Dec 2008 (T+90)
- 300 shares@ US$2.90Common Stock, par value $0.001 per shareSEC:0001161697-08-001064:0Canonical exit: 24 Dec 2008 (T+90)
- 100 shares@ US$2.95Common Stock, par value $0.001 per shareSEC:0001161697-08-001064:1Canonical exit: 24 Dec 2008 (T+90)
- 800 shares@ US$2.50Common Stock, par value $0.001 per shareSEC:0001161697-08-001040:0Canonical exit: 16 Dec 2008 (T+90)
- 500 shares@ US$2.55Common Stock, par value $0.001 per shareSEC:0001161697-08-001040:1Canonical exit: 16 Dec 2008 (T+90)
- 1,700 shares@ US$2.55Common Stock, par value $0.001 per shareSEC:0001161697-08-001040:2Canonical exit: 16 Dec 2008 (T+90)
- 1,993 shares@ US$3.01Common Stock, par value $0.001 per shareSEC:0001161697-08-000448:0
- 5,000 shares@ US$3.00Common StockSEC:0001161697-07-000940:0Canonical exit: 12 Nov 2007 (T+90)
12 of 12 declarations
